삼성서울병원

Ko En

obstetrics and gynecology Kim, Byoung Gie M.D

TITLE
Professor,Department of Obstetrics and Gynecology, Sungkyunkwan University School of Medicine
Treament Schedule 05 月
DATE
FRI
01
SAT
02
SUN
03
MON
04
TUE
05
WEB
06
THU
07
FRI
08
SAT
09
SUN
10
MON
11
TUE
12
WEB
13
THU
14
FRI
15
SAT
16
SUN
17
MON
18
TUE
19
WEB
20
THU
21
FRI
22
SAT
23
SUN
24
MON
25
TUE
26
WEB
27
THU
28
FRI
29
SAT
30
SUN
31
AM
PM
Treament Schedule 06 月
DATE
MON
01
TUE
02
WEB
03
THU
04
FRI
05
SAT
06
SUN
07
MON
08
TUE
09
WEB
10
THU
11
FRI
12
SAT
13
SUN
14
MON
15
TUE
16
WEB
17
THU
18
FRI
19
SAT
20
SUN
21
MON
22
TUE
23
WEB
24
THU
25
FRI
26
SAT
27
SUN
28
MON
29
TUE
30
AM
PM

Medical School

Seoul National University College of Medicine

Specialty Training

Fellowship   Division of Gynecologic Oncology
Department of Obstetrics and Gynecology
Seoul National University Hospital
Residency   Seoul National University Hospital
Internship   Seoul National University Hospital

Other Education

Guest researcher National Cancer Institute, Bethesda, MD, USA

Participation in Academic Societies
and Research

Active Member of American Association for Cancer Research
Active Member of International Gynecological Cancer Society
Member of Scientific Committee of Korean Cancer Association
Member of Scientific Committee of Korean Society of Gynecologic Oncology and Colposcopy
Active Member of Korean Society of Obstetics and Gynecology

Selected Publications

  • Asian Pac J Cancer Prev. 2019 Feb 26;20(2):425-435. Cost-Utility of a Two-Dose Human Papillomavirus Vaccination Programme Added to Cervical Cancer Screening Compared with Cervical Cancer Screening Alone in Korea Hyunju Lee1, Sooyoung Hur, Hyeongap Jang, I-Heng Lee, Woo-Yun Sohn, Georges Van Kriekinge, Byoung-Gie Kim
    View PubMed
  • J OVARIAN RES 2019 10.1186/s13048-019-0602-5 Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer Jeong1, SY; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Lee, YY
    View PubMed
  • J CLIN MED 2019 10.3390/jcm8111920 Real-World Experience of Olaparib Maintenance in High-Grade Serous Recurrent Ovarian Cancer Patients with BRCA1/2 Mutation: A Korean Multicenter Study Paik1, ES; Lee, YJ; Lee, JY; Shin, W; Park, SY; Kim, SI; Kim, JW; Choi, CH; Kim, BG
    View PubMed
  • NEW ENGL J MED 2019 10.1056/NEJMoa1902626 Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer Coleman1, RL; Spirtos, NM; Enserro, D; Herzog, TJ; Sabbatini, P; Armstrong, DK; Kim, JW; Park, SY; Kim, BG; Nam, JH; Fujiwara, K; Walker, JL; Casey, AC; Alvarez Secord, A; Rubin, S; Chan, JK; DiSilvestro, P; Davidson, SA; Cohn, DE; Tewari, KS; Basen-Engquist, K; Huang, HQ; Brady, MF; Mannel, RS
    View PubMed
  • J GYNECOL ONCOL 2019 10.3802/jgo.2019.30.e112 A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D Lee1, JY; Kim, JW; Lim, MC; Kim, S; Kim, HS; Choi, CH; Yi, JY; Park, SY; Kim, BG; Nam, EJ; Kim, SW; Eoh, KJ; Lee, YJ; Roh, J; Kim, HM; Rae, DS; Lee, JW; Kim, TJ; Lee, YY; Choi, EH; Song, S; Kim, HS; Lee, M; Kim, SI; Lee, EJ; Kwon, SI; Shin, W; Seo, SS; Kang, S; Kim, MS; Kim, JS; Joung, J; Chung, J
    View PubMed